ODI Pharma AB

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.

Quotes for ODI Pharma AB

Right Now

+/-
-0.03
%
−1,75%
Latest
1.68
High
2.06
Low
1.68
Volume
6 367
Turnover (SEK)
11 516
Market Value (MSEK)
26,7
Time (Latest trade)

Board

CEO

  • Jan-Mark Edewaard

Chairperson of the Board

  • Volker Wiederrich

Board

  • Gösta Lidén
  • Jan-Mark Edewaard
  • Karina Kilinski
  • Malcolm Allan
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    ODI Pharma AB - Company presentation

    Largest Owners

    Name Capital % Votes % Date
    Volker Wiederrich 38,53 38,53 2025-06-26
    Niclas Kappelin 29,37 29,37 2025-06-26
    Derek Simmross 23,23 23,23 2025-06-26
    Jan-Mark Edewaard 1,85 1,85 2025-06-26
    Tomi Kalevi Heikkinen 0,31 0,31 2025-03-27
    Avanza Pension 0,22 0,22 2025-03-27
    Carl Fredrik Christoffer Clementson 0,21 0,21 2025-03-27
    Nordnet Pensionsförsäkring 0,17 0,17 2025-03-27
    Nordnet Livsforsikring AS 0,15 0,15 2025-03-27
    Per Herseth 0,15 0,15 2025-03-27
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-08-29 Bokslutskommuniké 2025

    Annual reports, prospectus etc.